JJIJ
PHGE icon

Johnson & Johnson Innovation - JJDC’s BiomX PHGE Stock Holding History

Johnson & Johnson Innovation - JJDC’s Portfolio PHGE Stock Details PHGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		$11.6M Hold
11,228
– – 1.19% 9
2021
Q1 		$15.2M Hold
11,228
– – 1.97% 8
2020
Q4 		$13.6M Hold
11,228
– – 1.76% 7
2020
Q3 		$13.5M Hold
11,228
– – 2.72% 7
2020
Q2 		$11.8M Hold
11,228
– – 2.31% 8
2020
Q1 		$14.9M Hold
11,228
– – 8.13% 4
2019
Q4 		$20.7M Buy
+11,228
New +$19.4M 7.45% 2

Other funds holding PHGE

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
TWMP
Taylor Wealth Management Partners Boston, Massachusetts $176M AUM 14.65% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
RE
RBC Europe London, United Kingdom $2.08B AUM 12.2% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Johnson & Johnson Innovation - JJDC's PHGE Position: Q2 2021 in Review

Johnson & Johnson Innovation - JJDC held its BiomX (PHGE) position steady in Q2 2021 at 11,228 shares worth $11.6M. The position accounts for 1.19% of the portfolio, ranked #9.

Johnson & Johnson Innovation - JJDC first reported a position in PHGE in Q4 2019 and has held it in 7 quarters since. The position peaked at $20.7M in Q4 2019. 13 funds tracked by Wall St. Rank hold PHGE as of Q2 2021.

  • Johnson & Johnson Innovation - JJDC held 11,228 shares of BiomX worth $11.6M as of Q2 2021.
  • Johnson & Johnson Innovation - JJDC left its BiomX share count unchanged in Q2 2021.
  • BiomX made up 1.19% of Johnson & Johnson Innovation - JJDC's portfolio in Q2 2021, its #9 holding.
  • Johnson & Johnson Innovation - JJDC first reported a position in BiomX in Q4 2019 and has held it in 7 quarters since.
  • Johnson & Johnson Innovation - JJDC's BiomX position peaked at $20.7M in Q4 2019.
  • 13 funds tracked by Wall St. Rank held BiomX as of Q2 2021.

Based on Johnson & Johnson Innovation - JJDC's 13F filing for Q2 2021, filed 3 Aug 2021.